Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (1): 14-17.doi: 10.3969/j.issn.1000-6621.2019.01.005
• Expert Forum • Previous Articles Next Articles
Received:
2018-11-06
Online:
2019-01-10
Published:
2019-01-09
Hong-fei DUAN. To pay more attention to diagnosis and treatment of tuberculous meningitis[J]. Chinese Journal of Antituberculosis, 2019, 41(1): 14-17. doi: 10.3969/j.issn.1000-6621.2019.01.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.01.005
[1] |
Arvanitakis Z, Long RL, Hershfield ES , et al. M.tuberculosis molecular variation in CNS infection: evidence for strain-dependent neurovirulence. Neurology, 1998,50(6):1827-1832.
doi: 10.1212/WNL.50.6.1827 URL pmid: 9633735 |
[2] |
Hosogˇlu S, Ayaz C, Geyik MF , et al. Tuberculous meningitis in adults: an eleven-year review. Int J Tuberc Lung Dis, 1998,2(7):553-557.
URL pmid: 9661821 |
[3] |
Marais S, Pepper DJ, Schutz C , et al. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS One, 2011,6(5):e20077.
doi: 10.1371/journal.pone.0020077 URL pmid: 21625509 |
[4] |
Thwaites G, Fisher M, Hemingway C , et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect, 2009,59(3):167-187.
doi: 10.1016/j.jinf.2009.06.011 URL pmid: 19643501 |
[5] |
Patel VB, Theron G, Lenders L , et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med, 2013,10(10):e1001536.
doi: 10.1371/journal.pmed.1001536 URL pmid: 24167451 |
[6] |
杨元利, 张永峰, 刘元 , 等. GeneXpert MTB/RIF技术对成年人结核性脑膜炎诊断价值的研究. 中国防痨杂志, 2017,39(9):980-984.
doi: 10.3969/j.issn.1000-6621.2017.09.016 URL |
[7] |
Bahr NC, Nuwagira E, Evans EE , et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis, 2017,18(1):68-75.
doi: 10.1016/S1473-3099(17)30474-7 URL pmid: 28919338 |
[8] | Feng GD, Shi M, Ma L , et al. Diagnostic accuracy of intracellular Mycobacterium tuberculosis detection for tuberculous meningitis. Am J Respir Crit Care Med, 2014,189(4):475-481. |
[9] |
Thwaites GE, Macmullen-Price J, Tran TH , et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol, 2007,6(3):230-236.
doi: 10.1016/S1474-4422(07)70034-0 URL pmid: 17303529 |
[10] |
Marais S, Thwaites G, Schoeman JF , et al. Tuberculous me-ningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010,10(11):803-812.
doi: 10.1016/S1473-3099(10)70138-9 URL pmid: 20822958 |
[11] |
Thwaites GE, Chau TT, Stepniewska K , et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet, 2002,360(9342):1287-1292.
doi: 10.1016/S0140-6736(02)11318-3 URL pmid: 12414204 |
[12] | 张同强, 孙琳, 郭伟 , 等. 结核性脑膜炎评分系统对儿童结核性脑膜炎的诊断价值. 中国防痨杂志, 2018,40(9):932-939. |
[13] | Ellard GA, Humphries MJ, Allen BW . Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis, 1993,148(3):650-655. |
[14] |
Heemskerk AD, Bang ND, Mai NT , et al. Intensified antituberculosis therapy in adults with tuberculous meningitis. N Engl J Med, 2016,374(2):124-134.
doi: 10.1056/NEJMoa1507062 URL pmid: 26760084 |
[15] |
Ruslami R, Ganiem AR, Dian S , et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis, 2013,13(1):27-35.
doi: 10.1016/S1473-3099(12)70264-5 URL pmid: 23103177 |
[16] |
Thwaites GE, Nguyen DB, Nguyen HD , et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 2004,351(17):1741-1751.
doi: 10.1007/s11910-006-0045-4 URL pmid: 15963328 |
[17] | Wilkinson RJ, Rohlwink U, Misra UK , et al. Tuberculous meningitis. Nat Rev Neurol, 2017,13(10):581-598. |
[18] | Zhao Y, Xu S, Wang L , et al. National survey of drug-resis-tant tuberculosis in China. N Engl J Med, 2012,366(23):2161-2170. |
[19] |
Duo L, Ying B, Song X , et al. Molecular profile of drug resis-tance in tuberculous meningitis from southwest China. Clin Infect Dis, 2011,53(11):1067-1073.
doi: 10.1093/cid/cir663 |
[20] |
Vinnard C, Winston CA, Wileyto EP , et al. Isoniazid resis-tance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ, 2010,341:c4451.
doi: 10.1136/bmj.c4451 URL pmid: 2938884 |
[21] |
Berning SE, Cherry TA, Iseman MD . Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis, 2001,32(4):643-646.
doi: 10.1086/318698 URL pmid: 11181130 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||